The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease

Neuroscience Letters

Volumn 293, Issue 2, 2000, Pages 127-130

  Mellick, G D ^a,b   Silburn, P A ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Allele association study; Genetics; Parkinson's disease; Polymorphism; Ubiquitin carboxy terminal hydrolase L1

Indexed keywords

HYDROLASE; RESTRICTION ENDONUCLEASE; UBIQUITIN;

ADULT; AGED; ARTICLE; AUSTRALIA; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ASSAY; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCIBILITY;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; ELECTROPHORESIS, AGAR GEL; FEMALE; GENOTYPE; HUMAN; MALE; MIDDLE AGE; NERVE TISSUE PROTEINS; PARKINSON DISEASE; POLYMORPHISM (GENETICS); SERINE; SUPPORT, NON-U.S. GOV'T; THIOLESTER HYDROLASES; TYROSINE;

EID: 0034722106     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01510-X     Document Type: Article

References (14)

1. Calne D.B., Snow B.J., Lee C. Criteria for diagnosing Parkinson's disease. Ann. Neurol. 32:1992;S125-S127.
2. Farrer M., Gwinn-Hardy K., Muenter M., DeVrieze F.W., Crook R., Perez-Tur J., Lincoln S., Maraganore D., Adler C., Newman S., MacElwee K., McCarthy P., Miller C., Waters C., Hardy J. A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Hum. Mol. Genet. 8:1999;81-85.
3. Gasser T., Muller-Myhsok B., Wszolek Z.K., Oehlmann R., Calne D.B., Bonifati V., Bereznai B., Fabrizio E., Vieregge P., Horstmann R.D. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat. Genet. 18:1998;262-265.
4. Harhangi B.S., Farrer M.J., Lincoln S., Bonifati V., Meco G., De Michele G., Brice A., Durr A., Martinez M., Gasser T., Bereznai B., Vaughan J.R., Wood N.W., Hardy J., Oostra B.A., Breteler M.M. The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease. Neurosci. Lett. 270:1999;1-4.
5. Jackson P., Thompson R.J. The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis. J. Neurol. Sci. 49:1981;429-438.
6. Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M.J., Jonnalagada S., Chernova T., Dehejia A., Lavedan C., Gasser T., Steinbach P.J., Wilkinson K.D., Polymeropoulos M.H. The ubiquitin pathway in Parkinson's disease. Nature. 395:1998;451-452.
7. Lincoln S., Vaughan J., Wood N., Baker M., Adamson J., Gwinn-Hardy K., Lynch T., Hardy J., Farrer M. Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease. NeuroReport. 10:1999;427-429.
8. Lowe J., McDermott H., Kenward N., Landon M., Mayer R.J., Bruce M., McBride P., Somerville R.A., Hope J. Ubiquitin conjugate immunoreactivity in the brains of scrapie infected mice. J. Pathol. 162:1990;61-66.
9. Maraganore D.M., Farrer M.J., Hardy J.A., Lincoln S.J., McDonnell S.K., Rocca W.A. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Neurology. 53:1999;1858-1860.
10. Mellick G.D., Buchanan D.D., Silburn P.A., Chan D.K., Le Couteur D.G., Law L.K., Woo J., Pang C.P. The monoamine oxidase B gene GT repeat polymorphism and Parkinson's disease in a Chinese population. J. Neurol. 247:2000;52-55.
11. Nicholl D.J., Bennett P., Hiller L., Bonifati V., Vanacore N., Fabbrini G., Marconi R., Colosimo C., Lamberti P., Stocchi F., Bonuccelli U., Vieregge P., Ramsden D.B., Meco G., Williams A.C. A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology. 53:1999;1415-1421.
12. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
13. Saigoh K., Wang Y.L., Suh J.G., Yamanishi T., Sakai Y., Kiyosawa H., Harada T., Ichihara N., Wakana S., Kikuchi T., Wada K. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet. 23:1999;47-51.
14. Tassin J., Durr A., de Broucker T., Abbas N., Bonifati V., De Michele G., Bonnet A.M., Broussolle E., Pollak P., Vidailhet M., De Mari M., Marconi R., Medjbeur S., Filla A., Meco G., Agid Y., Brice A. Chromosome 6-linked autosomal recessive early-onset Parkinsonism: linkage in European and Algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family. The French Parkinson's Disease Genetics Study Group, and the European Consotium on Genetic Susceptibility in Parkinson's Disease. Am. J. Hum. Genet. 63:1998;88-94.